Supramolecular Nitric Oxide Depot for Hypoxic Tumor Vessel Normalization and Radiosensitization. 2022

Cuihong Yang, and Ganen Mu, and Ying Zhang, and Yang Gao, and Wenxue Zhang, and Jinjian Liu, and Wenwen Zhang, and Paiyun Li, and Lijun Yang, and Zhimou Yang, and Jie Gao, and Jianfeng Liu
Key Laboratory of Radiopharmacokinetics for Innovative Drugs, Chinese Academy of Medical Sciences, and Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, P. R. China.

In cancer radiotherapy, the lack of fixed DNA damage by oxygen in hypoxic microenvironment of solid tumors often leads to severe radioresistance. Nitric oxide (NO) is a potent radiosensitizer that acts in two ways. It can directly react with the radical DNA thus fixing the damage. It also normalizes the abnormal tumor vessels, thereby increasing blood perfusion and oxygen supply. To achieve these functions, the dosage and duration of NO treatment need to be carefully controlled, otherwise it will lead to the exact opposite outcomes. However, a delivery method that fulfills both requirements is still lacking. A NO depot is designed for the control of NO releasing both over quantity and duration for hypoxic tumor vessel normalization and radiosensitization. In B16-tumor-bearing mice, the depot can provide low dosage NO continuously and release large amount of NO immediately before irradiation for a short period of time. These two modes of treatment work in synergy to reverse the radioresistance of B16 tumors more efficiently than releasing at single dosage.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D011838 Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. Radiation Sensitizer,Radiosensitizing Agent,Radiosensitizing Agents,Agents, Radiation-Sensitizing,Radiation Sensitizers,Radiation Sensitizing Agents,Radiation-Sensitizing Drugs,Radiation-Sensitizing Effect,Radiation-Sensitizing Effects,Radiosensitizing Drugs,Radiosensitizing Effect,Radiosensitizing Effects,Agent, Radiosensitizing,Agents, Radiation Sensitizing,Agents, Radiosensitizing,Drugs, Radiation-Sensitizing,Drugs, Radiosensitizing,Effect, Radiation-Sensitizing,Effect, Radiosensitizing,Effects, Radiation-Sensitizing,Effects, Radiosensitizing,Radiation Sensitizing Drugs,Radiation Sensitizing Effect,Radiation Sensitizing Effects,Sensitizer, Radiation,Sensitizers, Radiation,Sensitizing Agents, Radiation
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D059016 Tumor Microenvironment The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth. Cancer Microenvironment,Cancer Microenvironments,Microenvironment, Cancer,Microenvironment, Tumor,Microenvironments, Cancer,Microenvironments, Tumor,Tumor Microenvironments

Related Publications

Cuihong Yang, and Ganen Mu, and Ying Zhang, and Yang Gao, and Wenxue Zhang, and Jinjian Liu, and Wenwen Zhang, and Paiyun Li, and Lijun Yang, and Zhimou Yang, and Jie Gao, and Jianfeng Liu
September 2008, Nitric oxide : biology and chemistry,
Cuihong Yang, and Ganen Mu, and Ying Zhang, and Yang Gao, and Wenxue Zhang, and Jinjian Liu, and Wenwen Zhang, and Paiyun Li, and Lijun Yang, and Zhimou Yang, and Jie Gao, and Jianfeng Liu
September 1996, International journal of radiation oncology, biology, physics,
Cuihong Yang, and Ganen Mu, and Ying Zhang, and Yang Gao, and Wenxue Zhang, and Jinjian Liu, and Wenwen Zhang, and Paiyun Li, and Lijun Yang, and Zhimou Yang, and Jie Gao, and Jianfeng Liu
December 1993, Cancer research,
Cuihong Yang, and Ganen Mu, and Ying Zhang, and Yang Gao, and Wenxue Zhang, and Jinjian Liu, and Wenwen Zhang, and Paiyun Li, and Lijun Yang, and Zhimou Yang, and Jie Gao, and Jianfeng Liu
December 1998, Cancer research,
Cuihong Yang, and Ganen Mu, and Ying Zhang, and Yang Gao, and Wenxue Zhang, and Jinjian Liu, and Wenwen Zhang, and Paiyun Li, and Lijun Yang, and Zhimou Yang, and Jie Gao, and Jianfeng Liu
November 2021, ACS biomaterials science & engineering,
Cuihong Yang, and Ganen Mu, and Ying Zhang, and Yang Gao, and Wenxue Zhang, and Jinjian Liu, and Wenwen Zhang, and Paiyun Li, and Lijun Yang, and Zhimou Yang, and Jie Gao, and Jianfeng Liu
April 2007, Cancer letters,
Cuihong Yang, and Ganen Mu, and Ying Zhang, and Yang Gao, and Wenxue Zhang, and Jinjian Liu, and Wenwen Zhang, and Paiyun Li, and Lijun Yang, and Zhimou Yang, and Jie Gao, and Jianfeng Liu
March 2021, Angewandte Chemie (International ed. in English),
Cuihong Yang, and Ganen Mu, and Ying Zhang, and Yang Gao, and Wenxue Zhang, and Jinjian Liu, and Wenwen Zhang, and Paiyun Li, and Lijun Yang, and Zhimou Yang, and Jie Gao, and Jianfeng Liu
May 2021, Advanced healthcare materials,
Cuihong Yang, and Ganen Mu, and Ying Zhang, and Yang Gao, and Wenxue Zhang, and Jinjian Liu, and Wenwen Zhang, and Paiyun Li, and Lijun Yang, and Zhimou Yang, and Jie Gao, and Jianfeng Liu
December 2019, Nature nanotechnology,
Cuihong Yang, and Ganen Mu, and Ying Zhang, and Yang Gao, and Wenxue Zhang, and Jinjian Liu, and Wenwen Zhang, and Paiyun Li, and Lijun Yang, and Zhimou Yang, and Jie Gao, and Jianfeng Liu
March 1975, Radiology,
Copied contents to your clipboard!